02.03.2013 Views

Pocket Program - CROI

Pocket Program - CROI

Pocket Program - CROI

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>CROI</strong> 2013 Session 125<br />

c Tuesday, 2:30-4 pm; Hall B2<br />

Session 124–Poster Abstracts<br />

Innate Immunity and Hepatitis C Virus<br />

696 Intra- and Extra-Hepatic Correlates of Plasma Viral<br />

Clearance in Patients with Chronic Hepatitis C Virus<br />

<br />

Eric Meissner* 1 , A Osinusi 1,2 , H Wang 3 , L Heytens 3 , A Nelson 1 ,<br />

M Polis 1 , H Masur 3 , W Symonds 4 , A Fauci 1 , and S Kottilil 1<br />

1 NIAID, NIH, Bethesda, MD, US;; 2 SAIC-Frederick, MD, US;; 3 Clinical<br />

Ctr, NIH, Bethesda, MD, US;; and 4 Gilead Sci, Foster City, CA, US<br />

697 <br />

<br />

<br />

Yu-Jin Lee* 1 , A Osinusi1,2 , M Kang3 , T Umbleja3 , V Amorosa4 ,<br />

S Kottilil1 , M Peters5 , and ACTG5269 Study Group<br />

1 2 3 NIH, Bethesda, MD, US;; SAIC-Frederick Inc, MD, US;; Harvard Sch of<br />

Publ Hlth, Boston, MA, US;; 4VAMC, Philadelphia, PA, US;; and 5Univ of<br />

California, San Francisco, US<br />

698 <br />

C Virus Viral Clearance and Sustained Virological Response<br />

in HIV/Hepatitis C Virus Co-infected Patients<br />

Antonio Rivero-Juarez* 1 , R Gonzalez1 , A Camacho1 ,<br />

B Manzanares-Martin1 , A Caruz2 , A Martinez-Peinado1 ,<br />

L Martinez-Duenas1 , J Pineda3 , J Pena1 , and A Rivero1 1Inst Maimonides de Investigacion Biomed de Cordoba, Hosp Reina Sofia de<br />

Cordoba, Spain;; 2Univ de Jaen, Spain;; and 3 708 Hepatitis C Virus Re-infections in HIV<br />

Hosp de Valme, Seville, Spain<br />

+ MSM: Evidence for<br />

Partial Protective Immunity<br />

X Thomas1 , B Grady2 , J van der Meer1 , F Lambers2 , M Prins1,2 ,<br />

M van der Valk2 , S Rebers1 , R Molenkamp1 , Janke Schinkel* 1 ,<br />

on behalf of MOSAIC Study Group<br />

1 2 Academic Med Ctr, Amsterdam, The Netherlands and Publ Hlth Svc,<br />

Amsterdam, The Netherlands<br />

709 Trends in Prevalence of Hepatitis C Virus among the HIV +<br />

Population: Spain<br />

Sergio Serrano-Villar* 1 , P Sobrino-Vegas2 , M Riera3 , JA Iribarren4 ,<br />

I Santos5 , R Rubio6 , L Munoz7 , B Clotet8 , J del Amo2 , S Moreno1 ,<br />

and CoRIS<br />

1 2 Hosp Univ Ramon y Cajal, Madrid, Spain;; Ctr Nacional de<br />

Epidemiologia, Inst de Salud Carlos III, Madrid, Spain;; 3Hosp Univ Son<br />

Espases, Palma, Spain;; 4Hosp Univ de Donostia, San Sebastian, Spain;;<br />

5 6 Hosp Univ de la Princesa, Madrid, Spain;; Hosp Univ Doce de Octubre,<br />

Madrid, Spain;; 7Hosp Univ San Cecilio, Granada, Spain;; and 8Hosp Univ<br />

Germans Trias i Pujol, Badalona, Spain<br />

704 Most Incident Hepatitis C Virus Infections among HIV +<br />

Persons in a Contemporary Cohort Are Not Acquired<br />

Parenterally<br />

Lynn Taylor* 1 , T Bush 2 , P Patel 2 , K Henry 3 , L Conley 2 , J Hammer 4 ,<br />

N Onen 5 , C Carpenter 1 , and J Brooks 2<br />

1 Brown Univ, Providence, RI, US;; 2 CDC, Atlanta, GA, US;; 3 Hennepin<br />

County Med Ctr, Minneapolis, MN, US;; 4 Denver Infectious Diseases<br />

Consultants, CO, US;; and 5 Washington Univ, St Louis, MO, US<br />

706 Acute Hepatitis C Virus Infection in Young Adults<br />

Carrie Jennings* and K Sherman<br />

Univ of Cincinnati Coll of Med, UC Hlth, OH, US<br />

707 Location on HIV Phylogeny Is Indicative of the Risk of<br />

Hepatitis C Virus Co-infection<br />

Roger Kouyos* 1,2 , A Rauch 3 , V Aubert 4 , S Yerly 5 , J Boni 1 ,<br />

T Klimkait 6 , B Ledergerber 1,2 , H Gunthard 1,2 , and Swiss HIV Cohort Study<br />

1 Univ of Zurich, Switzerland;; 2 Univ Hosp Zurich, Switzerland;; 3 Univ of<br />

Bern, Switzerland;; 4 Ctr Hosp Univ Vaudois, Lausanne, Switzerland;; 5 Univ<br />

Hosp Geneva, Switzerland;; and 6 Univ of Basel, Switzerland<br />

699 <br />

<br />

Clearance of Acute Hepatitis C in HIV + Patients<br />

Pavlos Kokordelis* 1 , B Kramer1 , C Boesecke1 , C Korner1 , E Voigt2 ,<br />

P Ingiliz3 , A Glassner1 , U Spengler1 , J Rockstroh1 , and J Nattermann1 1 2 Dept of Internal Med I, Bonn, Germany;; Praxis Theisen, Wiesel and Voigt,<br />

Cologne, Germany;; and 3Med Ctr for Infectious Diseases, Berlin, Germany<br />

700 <br />

<br />

Progression in HIV/Hepatitis C Virus Co-infected Patients<br />

Andreas Glassner*, P Kokordelis, M Eisenhardt, B Kramer, F Wolter,<br />

C Korner, C Boesecke, J Rockstroh, U Spengler, and J Nattermann<br />

Univ of Bonn, Germany<br />

701 HIV-associated Down-regulation of the Activating Natural<br />

<br />

and Natural Course of Hepatitis C Virus Infection<br />

Benjamin Kramer* 1 , P Kokordelis 1 , S Diegeler 1 , A Glassner 1 , M Eisenhardt 1 ,<br />

P Ingiliz 2 , C Boesecke 1 , U Spengler 1 , J Rockstroh 1 , and J Nattermann 1<br />

1 2 Univ of Bonn, Germany and Med Ctr for Infectious Diseases, Berlin,<br />

Germany<br />

702 <br />

Activity of Natural Killer Cells and May Be Involved in<br />

Spontaneous Clearance of Acute Hepatitis C in HIV + Patients<br />

Marianne Eisenhardt* 1 , A Glaessner1 , P Kokordelis1 , B Kraemer1 ,<br />

F Wolter1 , E Voigt2 , C Boesecke1 , U Spengler1 , J Rockstroh1 ,<br />

and J Nattermann1 1 2 Univ of Bonn, Germany and Ctr Theisen, Wiesel, and Voigt, Cologne,<br />

Germany<br />

703 <br />

Protein-10 in Patients Given an All-Oral Anti-Hepatitis C<br />

Virus Regimen<br />

Jennifer Lin* 1 , F Habersetzer2 , M Rodriguez-Torres3 , M Paulson4 ,<br />

Y Zhu4 , M Subramanian4 , J McHutchison4 , M Sulkowski5 , D Wyles1 ,<br />

and R Schooley1 1 2 Univ of California, San Diego, La Jolla, US;; Univ Hosp Strasbourg,<br />

France;; 3Fndn de Investigacion de Diego, San Juan, Puerto Rico;; 4Gilead Sci, Inc, Foster City, CA, US;; and 5 710 Prevalence of Hepatitis C Virus Infection in US Hispanics/<br />

Latinos: Results from the NHANES<br />

<br />

Mark Kuniholm*<br />

Johns Hopkins Univ Sch of Med,<br />

Baltimore, MD, US<br />

c Wednesday, 2:30-4 pm; Hall B2<br />

Session 125–Poster Abstracts<br />

Hepatitis C Virus Epidemiology and Clinical Outcomes<br />

1 , M Jung1 , J Everhart2 , S Cotler3 , G Heiss4 ,<br />

G McQuillan5 , B Thyagarajan6 , M Youngblood4 , R Kaplan1 , and G Ho1 1 2 Albert Einstein Coll of Med, Bronx, NY, US;; Natl Inst of Diabetes<br />

and Digestive and Kidney Diseases, NIH, Bethesda, MD, US;; 3Univ of Illinois, Chicago, US;; 4Univ of North Carolina at Chapel Hill, US;;<br />

5 6 CDC, Hyattsville, MD, US;; and Univ of Minnesota Med Ctr, Fairview,<br />

Minneapolis, US<br />

711 Diversity of Hepatitis C Virus Infection among HIV + <br />

Drugs Users in India: Implications for HIV and Hepatitis C<br />

Virus Treatment<br />

Sunil Solomon* 1,2,3 , S Shanmugam2 , A Srikrishnan2 , S Iqbal2 ,<br />

C Vasudevan2 , M Kumar2 , D Persaud1 , S Solomon2 , S Ray1 , and S Mehta3 1 2 Johns Hopkins Univ Sch of Med, Baltimore, MD, US;; YRG CARE,<br />

Chennai, India;; and 3Johns Hopkins Univ Bloomberg Sch of Publ Hlth,<br />

Baltimore, MD, US<br />

712 Identifying Priorities for Improving Hepatitis C Virus Care<br />

in the Era of Directly Acting Antiviral Therapy<br />

Benjamin Linas* 1,2 , D Barter1 , J Leff3 , S Assoumou1 , A Kim4 ,<br />

and B Schackman3 1 2 3 Boston Med Ctr, MA, US;; Boston Univ Sch of Publ Hlth, MA, US;; Weill<br />

Cornell Med Coll, New York, NY, US;; and 4Massachusetts Gen Hosp,<br />

Boston, US<br />

713 Using an HIV Primary Care Model for the Treatment of<br />

Hepatitis C<br />

Lucas Hill*, C Ballard, B Colwell, D Wyles, F Torriani, W Mathews,<br />

and E Cachay<br />

Univ of California, San Diego, US<br />

714 <br />

of Hepatitis C Virus Transmission: A Mathematical Model<br />

Viviane Lima* 1 , B Nosyk1 , M Krajden2 , M Hull1 , T Kerr1 , E Wood1 ,<br />

E Yoshida3 , Z Wu4 , and J Montaner1 1 2 BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada;; BC Ctr<br />

for Disease Control, Vancouver, Canada;; 3Univ of British Columbia,<br />

Vancouver, Canada;; and 4Natl Ctr for AIDS/STD Control and Prevention,<br />

Chinese Ctr for Disease Control and Prevention, Beijing<br />

715 The Effect of Hepatitis C Virologic Clearance on Cardiovascular<br />

Disease Biomarkers in HIV/Hepatitis C Virus Co-infection<br />

Kara Chew* 1 , L Hua2 , D Bhattacharya1 , A Butt3,4 , R Chung5 ,<br />

J Andersen2 , and J Currier1 1 2 David Geffen Sch of Med, Univ of California, Los Angeles, US;; Harvard<br />

Sch of Publ Hlth, Boston, MA, US;; 3Univ of Pittsburgh Sch of Med, PA,<br />

US;; 4Sheikh Khalifa Med City, Abu Dhabi, United Arab Emirates;; and<br />

5Harvard Med Sch, Massachusetts Gen Hosp, Boston, US<br />

716 <br />

Hepatitis C Virus and HIV/Hepatitis C Virus<br />

Kara Chew*<br />

705 Acute Hepatitis C Virus Infection in Studies of Elvitegravir/<br />

<br />

<br />

Erin Quirk*, H Graham, H Liu, and J Szwarcberg<br />

Gilead Sci Inc, Foster City, CA, US<br />

1 , D Bhattacharya1 , K McGinnis2 , J Currier1 , and A Butt3,4 1 2 David Geffen Sch of Med, Univ of California, Los Angeles, US;; VA<br />

Pittsburgh Hlthcare System, PA, US;; 3Univ of Pittsburgh Sch of Med, PA,<br />

US;; and 4Sheikh Khalifa Med City, Abu Dhabi, United Arab Emirates<br />

717 Methamphetamine Promotes Cardiac Dysfunction in<br />

Genetically Engineered Hepatitis C Virus Mice<br />

Rebecca Torres*, E Fields, C Koczor, R Russ, T Ludaway,<br />

K Jackson, Q Qin, and W Lewis<br />

Emory Univ, Atlanta, GA, US<br />

<strong>Program</strong> 49<br />

Poster Listings

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!